Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.81 | -16.67 |
PEG Ratio (TTM) | -0.31 | -5.49 |
P/S Ratio (TTM) | 0.08 | 37.47 |
P/B Ratio (TTM) | -1.69 | 5.86 |
P/FCF Ratio (TTM) | 4.09 | -148.99 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.86% | 284.65% |
ROE (TTM) | 16.21% | -4,181.05% |
Net Profit Margin (TTM) | -0.71% | -1,000.23% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -64.54% | 3,398.65% | N/A |
Revenue | 9.07% | 21.10% | N/A |
Net Income | -69.38% | 717.06% | N/A |
Cash Flow | 42.81% | -87.85% | N/A |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.36 | 4.92 |
Quick Ratio (TTM) | 1.11 | 4.89 |
D/E Ratio (TTM) | -2.35 | 1.28 |
Interest Coverage (TTM) | -6.26 | -11.13 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | 4.34 | 20.79 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.85% |